Create account

Coverage dated March 7, 2024 to March 8, 2024

FDA approves Wegovy to reduce heart attack and stroke risk

Headline from Fox10 Phoenix, from the development of Mar 8, 2024

Newest development Mar 9, 2024 · 2 reportsFDA approves Wegovy for lowering heart attack and stroke risk in overweight patients

The U.S. Food and Drug Administration approved a label change that expands the use of the drug in Wegovy. It was previously approved to treat obesity.

Fox10 Phoenix's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Developments in this update

2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.

  1. Names this update

    FDA approves Wegovy to reduce heart attack and stroke risk

    Headline from Fox10 Phoenix ·

  2. Newest

    FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients

    Headline from NPR ·

Read the reports

Reports & sources

19 articles, oldest first.

  1. New York Post

    Weight-loss drug Wegovy approved by FDA to cut heart attack, stroke risk (opens New York Post)

    Published

    New York Post's feed description

    The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, federal regulators said Friday.

  2. Minneapolis Star Tribune

    Obesity drug Wegovy is approved to cut heart attack and stroke risk in overweight patients (opens Minneapolis Star Tribune)

    Published

    Minneapolis Star Tribune's feed description

    The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, federal regulators said Friday.

  3. Fox10 Phoenix

    FDA approves Wegovy to reduce heart attack and stroke risk (opens Fox10 Phoenix)

    Published

    Fox10 Phoenix's feed description

    The U.S. Food and Drug Administration approved a label change that expands the use of the drug in Wegovy. It was previously approved to treat obesity.

  4. Washington Post

    FDA approves weight-loss drug Wegovy to reduce heart-disease risks (opens Washington Post)

    Published

    Washington Post's feed description

    The U.S. Food and Drug administration approved the weight-loss drug Wegovy as a treatment to reduce cardiovascular risk in adults who are overweight, the first approval of its kind.

  5. Digital Journal

    US FDA approves Wegovy to cut risk of heart problems (opens Digital Journal)

    Published

    Digital Journal's feed description

    The US Food and Drug Administration has given the green light for a popular anti-obesity drug to be used to prevent serious heart conditions for the first

  6. NPR

    FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients (opens NPR)

    Published

    NPR's feed description

    The popular weight-loss drug can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, the FDA said.

  7. New Hampshire Union Leader

    FDA approves Novo Nordisk drug Wegovy for use in lowering heart attack risks (opens New Hampshire Union Leader)

    Published

    New Hampshire Union Leader's feed description

    The Food and Drug Administration approved Novo Nordisk’s weight-loss drug Wegovy on Friday for lowering the risk of stroke and heart attack in overweight or obese adults who are not

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.